Rhea M Shields

Array ( [id] => 9375560 [patent_doc_number] => 08679824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Fermentation broth formulations' [patent_app_type] => utility [patent_app_number] => 13/201997 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 15745 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228835 [patent_doc_number] => 20100183573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'HEPATOCYTE GROWTH FACTOR RECEPTOR SPLICE VARIANTS AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/709269 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 47357 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183573.pdf [firstpage_image] =>[orig_patent_app_number] => 12709269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534329 [patent_doc_number] => 20100204087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'TRIBONECTINS' [patent_app_type] => utility [patent_app_number] => 12/703036 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9624 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204087.pdf [firstpage_image] =>[orig_patent_app_number] => 12703036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427623 [patent_doc_number] => 08703698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Compositions and methods for treating atherosclerosis' [patent_app_type] => utility [patent_app_number] => 12/701709 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27059 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12701709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506076 [patent_doc_number] => 20100210510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ORAL LACTOFERRIN IN THE TREATMENT OF SEPSIS' [patent_app_type] => utility [patent_app_number] => 12/702216 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13396 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210510.pdf [firstpage_image] =>[orig_patent_app_number] => 12702216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227334 [patent_doc_number] => 08633001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Process for producing optically active succinimide derivatives and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 13/148263 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10439 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320350 [patent_doc_number] => 20100196348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'COMBINATION TREATMENT WITH t-PA VARIANT AND LOW MOLECULAR WEIGHT HEPARIN' [patent_app_type] => utility [patent_app_number] => 12/701436 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11257 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196348.pdf [firstpage_image] =>[orig_patent_app_number] => 12701436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8470039 [patent_doc_number] => 08299217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Variant AXMI-R1 delta endotoxin genes and methods for their use' [patent_app_type] => utility [patent_app_number] => 12/701058 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21218 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12701058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617668 [patent_doc_number] => 20130022980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'RNA- AND DNA-COPYING ENZYMES' [patent_app_type] => utility [patent_app_number] => 13/147446 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16408 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499619 [patent_doc_number] => 20100209955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Methods For The Delivery Of Toxins Or Enzymatically Active Portions Thereof' [patent_app_type] => utility [patent_app_number] => 12/690427 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19220 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209955.pdf [firstpage_image] =>[orig_patent_app_number] => 12690427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8200928 [patent_doc_number] => 08188041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 12/689623 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 34 [patent_no_of_words] => 17126 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188041.pdf [firstpage_image] =>[orig_patent_app_number] => 12689623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685252 [patent_doc_number] => 20100120889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'SKIN CARE COMPOSITION FOR ACCELERATED PRODUCTION OF COLLAGEN PROTEINS AND METHOD OF FABRICATING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/688785 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3724 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120889.pdf [firstpage_image] =>[orig_patent_app_number] => 12688785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637122 [patent_doc_number] => 20100173838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'NOVEL PROCESS FOR THE PREPARATION OF CYCLOSPORIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/685965 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8942 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173838.pdf [firstpage_image] =>[orig_patent_app_number] => 12685965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453711 [patent_doc_number] => 20100105603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Methods and Preparations For Curing Clinically Ill Patients' [patent_app_type] => utility [patent_app_number] => 12/683062 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12013 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105603.pdf [firstpage_image] =>[orig_patent_app_number] => 12683062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586822 [patent_doc_number] => 20110281332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'OCHROBACTRUM SP. FOR DEGRADING TETRABROMOBISPHENOL-A (TBBPA) AND ITS APPLICATION' [patent_app_type] => utility [patent_app_number] => 12/995567 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1859 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281332.pdf [firstpage_image] =>[orig_patent_app_number] => 12995567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295264 [patent_doc_number] => 20100160231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'AXMI-150 DELTA-ENDOTOXIN GENE AND METHODS FOR ITS USE' [patent_app_type] => utility [patent_app_number] => 12/646004 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18567 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160231.pdf [firstpage_image] =>[orig_patent_app_number] => 12646004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183697 [patent_doc_number] => 08623629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Polypeptides with xylanase activity' [patent_app_type] => utility [patent_app_number] => 13/141444 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 28271 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344161 [patent_doc_number] => 20100330184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'INJECTION VEHICLE FOR POLYMER-BASED FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/642727 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7560 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330184.pdf [firstpage_image] =>[orig_patent_app_number] => 12642727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778279 [patent_doc_number] => 20120040911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'TARGETED DELIVERY OF BOTULINUM TOXIN FOR THE TREATMENT AND PREVENTION OF TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE AND VASCULAR CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/642545 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040911.pdf [firstpage_image] =>[orig_patent_app_number] => 12642545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6533702 [patent_doc_number] => 20100204054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS FOR IDENTIFYING INHIBITORS OF BOTULINUM NEUROTOXINS' [patent_app_type] => utility [patent_app_number] => 12/630336 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7753 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204054.pdf [firstpage_image] =>[orig_patent_app_number] => 12630336 [rel_patent_id] =>[rel_patent_doc_number] =>)